The transmission and infectivity of COVID-19 have caused a pandemic that has lasted for several years. This is due to the constantly changing variants and subvariants that have evolved rapidly from SARS-CoV-2. To discover drugs with therapeutic potential for COVID-19, we focused on the 3CL protease (3CL) of SARS-CoV-2, which has been proven to be an important target for COVID-19 infection.
View Article and Find Full Text PDF